AOD9604 10 mg
AOD9604 is a synthetic peptide related to the C-terminal region of human growth hormone. Research focuses on lipid metabolism and how this fragment influences metabolic signaling compared with the full-length hormone.
AOD9604 5 mg
AOD9604 is a synthetic peptide related to the C-terminal region of human growth hormone. Research focuses on lipid metabolism and how this fragment influences metabolic signaling compared with the full-length hormone.
PT-141 10 mg
PT-141, also called bremelanotide, is a synthetic peptide associated with melanocortin receptor research. It is investigated for receptor binding and the downstream signals involved in neuroendocrine communication.
Retatrutide 10 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 15 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 20 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 30 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 40 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 5 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 50 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Retatrutide 60 mg
Retatrutide is a synthetic peptide investigated for activity at GLP-1, GIP and glucagon receptors. Research examines how these receptor systems contribute to metabolic signaling, glucose regulation and cellular energy balance.
Tirzepatide 10 mg
Tirzepatide is a synthetic peptide that interacts with both GIP and GLP-1 receptors. Laboratory research explores its role in incretin signaling and the cellular pathways involved in glucose handling and energy regulation.
Tirzepatide 15 mg
Tirzepatide is a synthetic peptide that interacts with both GIP and GLP-1 receptors. Laboratory research explores its role in incretin signaling and the cellular pathways involved in glucose handling and energy regulation.
Tirzepatide 20 mg
Tirzepatide is a synthetic peptide that interacts with both GIP and GLP-1 receptors. Laboratory research explores its role in incretin signaling and the cellular pathways involved in glucose handling and energy regulation.
Tirzepatide 30 mg
Tirzepatide is a synthetic peptide that interacts with both GIP and GLP-1 receptors. Laboratory research explores its role in incretin signaling and the cellular pathways involved in glucose handling and energy regulation.
Tirzepatide 40 mg
Tirzepatide is a synthetic peptide that interacts with both GIP and GLP-1 receptors. Laboratory research explores its role in incretin signaling and the cellular pathways involved in glucose handling and energy regulation.
